Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality

Gastroenterology

Volumn 130, Issue 3, 2006, Pages 703-714

  Tanaka, Yasuhito ^a   Kurbanov, Fuat ^a   Mano, Shuhei ^b   Orito, Etsuro ^a   Vargas, Victor ^c   Esteban, Juan I ^c   Yuen, Man Fung ^d   Lai, Ching Lung ^d   Kramvis, Anna ^e   Kew, Michael C ^e   Smuts, Heidi E ^f   Netesov, Sergey V ^g   Alter, Harvey J ^h   Mizokami, Masashi ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b NAGOYA CITY UNIVERSITY   (Japan)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

^e SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^f UNIVERSITY OF CAPE TOWN   (South Africa)

^g STATE RESEARCH CENTER OF VIROLOGY AND BIOTECHNOLOGY VECTOR   (Russian Federation)

^h NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL GENE; GENE SEQUENCE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEPATITIS C; HEPATITIS C VIRUS; LIVER CELL CARCINOMA; MORTALITY; PRIORITY JOURNAL; SEROPREVALENCE; VIRUS ISOLATION; VIRUS STRAIN;

EID: 33644863680     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2006.01.032     Document Type: Article

References (54)

1. M.J. Alter Epidemiology of hepatitis C in the West Semin Liver Dis 15 1995 5 14
2. C.J. Mansell, S.A. Locarnini Epidemiology of hepatitis C in the East Semin Liver Dis 15 1995 15 32
3. Y. Shiratori, S. Shiina, M. Imamura, N. Kato, F. Kanai, T. Okudaira, T. Teratani, G. Tohgo, N. Toda, M. Ohashi Characteristic difference of hepatocellular carcinoma between hepatitis B- and C-viral infection in Japan Hepatology 22 1995 1027 1033
4. K. Kiyosawa, T. Sodeyama, E. Tanaka, Y. Gibo, K. Yoshizawa, Y. Nakano, S. Furuta, Y. Akahane, K. Nishioka, R.H. Purcell Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma analysis by detection of antibody to hepatitis C virus Hepatology 12 1990 671 675
5. F.X. Lopez-Labrador, S. Ampurdanes, X. Forns, A. Castells, J.C. Saiz, J. Costa, J. Bruix, J.M. Sanchez Tapias, M.T. Jimenez de Anta, J. Rodes Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma J Hepatol 27 1997 959 965
6. M. Colombo, G. Kuo, Q.L. Choo, M.F. Donato, E. Del Ninno, M.A. Tommasini, N. Dioguardi, M. Houghton Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma Lancet 2 1989 1006 1008
7. P. Simmonds, E.C. Holmes, T.A. Cha, S.W. Chan, F. McOmish, B. Irvine, E. Beall, P.L. Yap, J. Kolberg, M.S. Urdea Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region J Gen Virol 74 1993 2391 2399
8. J. Bukh, R.H. Purcell, R.H. Miller Sequence analysis of the core gene of 14 hepatitis C virus genotypes Proc Natl Acad Sci U S A 91 1994 8239 8243
9. B. Robertson, G. Myers, C. Howard, T. Brettin, J. Bukh, B. Gaschen, T. Gojobori, G. Maertens, M. Mizokami, O. Nainan, S. Netesov, K. Nishioka, I.T. Shin, P. Simmonds, D. Smith, L. Stuyver, A. Weiner International Committee on Virus Taxonomy Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses proposals for standardization Arch Virol 143 1998 2493 2503
10. M.U. Mondelli, E. Silini Clinical significance of hepatitis C virus genotypes J Hepatol 31 Suppl 1 1999 65 70
11. D.B. Smith, S. Pathirana, F. Davidson, E. Lawlor, J. Power, P.L. Yap, P. Simmonds The origin of hepatitis C virus genotypes J Gen Virol 78 1997 321 328
12. N.A. Rosenberg, M. Nordborg Genealogical trees, coalescent theory and the analysis of genetic polymorphisms Nat Rev Genet 3 2002 380 390
13. O.G. Pybus, M.A. Charleston, S. Gupta, A. Rambaut, E.C. Holmes, P.H. Harvey The epidemic behavior of the hepatitis C virus Science 292 2001 2323 2325
14. Y. Tanaka, K. Hanada, M. Mizokami, A.E. Yeo, J.W. Shih, T. Gojobori, H.J. Alter A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades Proc Natl Acad Sci U S A 99 2002 15584 15589
15. Y. Tanaka, K. Hanada, E. Orito, Y. Akahane, K. Chayama, H. Yoshizawa, T. Kato, M. Sata, N. Ohta, Y. Miyakawa, T. Gojobori, M. Mizokami Molecular evolutionary analyses implicate injection treatment for schistosomiasis in the initial hepatitis C endemic of Japan J Hepatol 42 2005 47 53
16. F. Kurbanov, Y. Tanaka, F. Sugauchi, H. Kato, R. Ruzibakiev, M. Zalyalieva, Z. Yunusova, M. Mizokami Hepatitis C virus molecular epidemiology in Uzbekistan J Med Virol 69 2003 367 375
17. A.V. Shustov, G.V. Kochneva, G.F. Sivolobova, A.A. Grazdantseva, I.V. Gavrilova, L.A. Akinfeeva, I.G. Rakova, M.B. Aleshina, V.N. Bukin, V.G. Orlovsky, V.S. Bespalov, A. Zelicoff, S.V. Netesov The occurrence of the markers distribution of genotypes and risk factors for viral hepatitis C among some groups of the population in the Novosibirsk Region Zh Mikrobiol Epidemiol Immunobiol 5 2004 20 25
18. Y. Tanaka, S. Agha, N. Saudy, F. Kurbanov, E. Orito, T. Kato, M. Abo-Zeid, M. Khalaf, Y. Miyakawa, M. Mizokami Exponential spread of hepatitis C virus genotype 4a in Egypt J Mol Evol 58 2004 191 195
19. T. Ohno, M. Mizokami, R.R. Wu, M.G. Saleh, K. Ohba, E. Orito, M. Mukaide, R. Williams, J.Y. Lau New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a J Clin Microbiol 35 1997 201 207
20. J. Dopazo Estimating errors and confidence intervals for branch lengths in phylogenetic trees by a bootstrap approach J Mol Evol 38 1994 300 304
21. S. Kumar, K. Tamura, I.B. Jakobsen, M. Nei MEGA2 molecular evolutionary genetics analysis software Bioinformatics 17 2001 1244 1245
22. T. Nakano, L. Lu, P. Liu, O.G. Pybus Viral gene sequences reveal the variable history of hepatitis C virus infection among countries J Infect Dis 19 2004 1098 1108
23. O.G. Pybus, A. Rambaut GENIE estimating demographic history from molecular phylogenies Bioinformatics 18 2002 1404 1405
24. P. Lemey, O.G. Pybus, B. Wang, N.K. Saksena, M. Salemi, A.M. Vandamme Tracing the origin and history of the HIV-2 epidemic Proc Natl Acad Sci U S A 100 2003 6588 6592
25. O.G. Pybus, A.J. Drummond, T. Nakano, B.H. Robertson, A. Rambaut The epidemiology and iatrogenic transmission of hepatitis C virus in Egypt a Bayesian coalescent approach Mol Biol Evol 20 2003 381 387
26. G.M. Jenkins, A. Rambaut, O.G. Pybus, E.C. Holmes Rates of molecular evolution in RNA viruses a quantitative phylogenetic analysis J Mol Evol 54 2002 156 165
27. S. Deuffic, L. Buffat, T. Poynard, A.J. Valleron Modeling the hepatitis C virus epidemic in France Hepatology 29 1999 1596 1601
28. V. Baldo, A. Floreani, T. Menegon, G. Angiolelli, R. Trivello The Collaborative Group Prevalence of antibodies against hepatitis C virus in the elderly a seroepidemiological study in a nursing home and in an open population Gerontology 46 2000 194 198
29. S. Deuffic, T. Poynard, A.J. Valleron Correlation between hepatitis C virus prevalence and hepatocellular carcinoma mortality in Europe J Viral Hepat 6 1999 411 413
30. A. Wasley, M.J. Alter Epidemiology of hepatitis C geographic differences and temporal trends Semin Liver Dis 20 2000 1 16
31. R.C. Griffiths, S. Tavare Sampling theory for neutral alleles in a varying environment Philos Trans R Soc Lond B Biol Sci 344 1994 403 410
32. H. Yoshizawa Hepatocellular carcinoma associated with hepatitis C virus infection in Japan projection to other countries in the foreseeable future Oncology 62 Suppl 1 2002 8 17
33. F. Iida, R. Iida, H. Kamijo, K. Takaso, Y. Miyazaki, W. Funabashi, K. Tsuchiya, Y. Matsumoto Chronic Japanese schistosomiasis and hepatocellular carcinoma ten years of follow-up in Yamanashi Prefecture, Japan Bull World Health Organ 77 1999 573 581
34. S. Fukui, K. Wada, M. Iyo History and current use of methamphetamine in Japan Proceedings of Japan-US Scientific Symposium '90 on Drug Dependence and Abuse; September 7-8, 1990; Tokyo, Japan. Cocaine and methamphetamine behavioral toxicology, clinical psychiatry and epidemiology. Proceedings of the Japan-U.S. Scientific Symposium '90 on Drug Dependence and Abuse, September 7-8, 1990, International Lecture Hall, National Cancer Center in Tokyo 1991 219 237
35. C. La Vecchia, F. Lucchini, E. Negri, P. Boyle, P. Maisonneuve, F. Levi Trends of cancer mortality in Europe, 1955-1989 I, Digestive sites Eur J Cancer 28 1992 132 235
36. M.J. Alter, D. Kruszon-Moran, O.V. Nainan, G.M. McQuillan, F. Gao, L.A. Moyer, R.A. Kaslow, H.S. Margolis The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 N Engl J Med 341 1999 556 562
37. H.R. Rosen, S. Chou, A.W. Sasaki, D.R. Gretch Molecular epidemiology of hepatitis C infection in US veteran liver transplant recipients evidence for decreasing relative prevalence of genotype 1B Am J Gastroenterol 94 1999 3015 3019
38. C.D. Chambers Some epidemiological considerations of onset of opiate use in the United States E.C. Josephson E.E. Carroll Drug use epidemiological and sociological approaches 1973 Hemisphere Publishing Washington 65 82
39. M.J. Alter Hepatitis C virus infection in the United States J Hepatol 1 1999 88 91
40. M.J. Alter, Y.J.F. Hutin, G.L. Armstrong Epidemiology of hepatitis C virus T.J. Liang J.H. Hoofnagle Hepatitis C 2000 Academic Press San Diego 163 183
41. O. Kalinina, H. Norder, T. Vetrov, K. Zhdanov, M. Barzunova, V. Plotnikova, S. Mukomolov, L.O. Magnius Shift in predominating subtype of HCV from 1b to 3a in St. Petersburg mediated by increase in injecting drug use J Med Virol 65 2001 517 524
42. D.A. Wong, L.K. Tong, W. Lim High prevalence of hepatitis C virus genotype 6 among certain risk groups in Hong Kong Eur J Epidemiol 14 1998 421 426
43. J. Ribes, R. Cleries, J. Borras, J. Galceran, F.X. Bosch Time trends in incidence and mortality for chronic liver disease and liver cancer in the interval 1980-1997 in Catalonia, Spain Eur J Gastroenterol Hepatol 16 2004 865 872
44. F.X. Bosch, J. Ribes, M. Diaz, R. Cleries Primary liver cancer worldwide incidence and trends Gastroenterology 127 2004 S5 S16
45. H. Yoshida, Y. Shiratori, M. Moriyama, Y. Arakawa, T. Ide, M. Sata, O. Inoue, M. Yano, M. Tanaka, S. Fujiyama, S. Nishiguchi, T. Kuroki, F. Imazeki, O. Yokosuka, S. Kinoyama, G. Yamada, M. Omata IHIT Study Group Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. Inhibition of Hepatocarcinogenesis by Interferon Therapy Ann Intern Med 131 1999 174 181
46. M.C. Kew Chronic hepatitis B virus infection and hepatocellular carcinoma in Africa S Afr J Sci 88 1992 524 528
47. N.W. Leung, J.S. Tam, J.Y. Lai, T.W. Leung, W.Y. Lau, W. Shiu, A.K. Li Does hepatitis C virus infection contribute to hepatocellular carcinoma in Hong Kong? Cancer 70 1992 40 44
48. F.X. Bosch, J. Ribes, R. Cleries, M. Diaz Epidemiology of hepatocellular carcinoma Clin Liver Dis 9 2005 191 211 v
49. A. Rahman El-Zayadi, H. Abaza, S. Shawky, M.K. Mohamed, O.E. Selim, H.M. Badran Prevalence and epidemiological features of hepatocellular carcinoma in Egypt - a single center experience Hepatol Res 19 2001 170 179
50. K. Kiyosawa, T. Umemura, T. Ichijo, A. Matsumoto, K. Yoshizawa, A. Gad, E. Tanaka Hepatocellular carcinoma recent trends in Japan Gastroenterology 127 2004 S17 S26
51. J.A. del Olmo, M.L. Garcia-Torres, R. Ginger, J. Primo, A. Zaragoza Incidence and epidemiological factors of hepatocellular carcinoma in Valencia, Spain during the year 2000 Rev Esp Enferm Dig 95 2003 381 384
52. H.B. El-Serag, A.C. Mason Rising incidence of hepatocellular carcinoma in the United States N Engl J Med 340 1999 745 750
53. T.J. Tucker, M. Voigt, A. Bird, S. Robson, B. Gibbs, J. Kannemeyer, M. Galloway, R.E. Kirsch, H. Smuts Hepatitis C virus infection rate in volunteer blood donors from the Western Cape - comparison of screening tests and PCR S Afr Med J 87 1997 603 605
54. P.N. Soni, D.R. Tait, D.G. Kenoyer, F. Fernandes-Costa, S. Naicker, W. Gopaul, A.E. Simjee Hepatitis C virus antibodies among risk groups in a South African area endemic for hepatitis B virus J Med Virol 40 1993 65 68